Treatment Options for Bilateral Invasive Mammary Carcinoma with Mucinous Features

Initial Evaluation and Staging

A repeat axillary lymph node biopsy is necessary since the initial attempt did not identify lymphoid tissue, which is crucial for proper staging 1
Complete staging workup should include bilateral diagnostic mammography, pathology review, determination of tumor estrogen receptor (ER), progesterone receptor (PR), and HER2 status 1, 2

Breast-conserving surgery (lumpectomy) with sentinel lymph node biopsy is the standard approach for invasive carcinoma when feasible 1, 2
For bilateral disease, bilateral sentinel lymph node biopsies should be performed 2
If breast conservation is not feasible due to tumor size relative to breast size or patient preference, bilateral mastectomy with sentinel lymph node biopsy would be appropriate 2, 3

Postoperative radiation therapy is strongly recommended after breast-conserving surgery to reduce local recurrence risk by approximately two-thirds 2, 3
For a patient with hormone receptor-positive disease, adjuvant endocrine therapy with an aromatase inhibitor or tamoxifen should be administered 3
For patients over 70 years with receptor-positive invasive breast cancer with clear postoperative margins, adjuvant tamoxifen instead of radiation therapy may be considered in select cases 3
Adjuvant chemotherapy decisions should be based on tumor characteristics, including hormone receptor status, HER2 status, and tumor grade 2

Risk assessment should consider age, tumor size, histological grade, vascular invasion, lymph node involvement, and receptor status 3, 5

Inadequate axillary staging - ensure proper lymph node sampling is obtained since the initial biopsy was inconclusive 1
Failure to consider the patient's age and comorbidities when planning treatment intensity 3